Anti-CTLA-4 antibody-induced Guillain-Barre syndrome in a melanoma patient

被引：132

作者：

Wilgenhof, S. ^{[1
]}

Neyns, B. ^{[1
]}

机构：

[1] Univ Ziekenhuis Brussel, Dept Med Oncol, Brussels, Belgium

来源：

ANNALS OF ONCOLOGY | 2011年 / 22卷 / 04期

关键词：

EFFICACY;

D O I：

10.1093/annonc/mdr028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：991 / 993

页数：3

相关论文

共 5 条

[1]

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[2]

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study [J].

O'Day, S. J. ;

Maio, M. ;

Chiarion-Sileni, V. ;

Gajewski, T. F. ;

Pehamberger, H. ;

Bondarenko, I. N. ;

Queirolo, P. ;

Lundgren, L. ;

Mikhailov, S. ;

Roman, L. ;

Verschraegen, C. ;

Humphrey, R. ;

Ibrahim, R. ;

de Pril, V. ;

Hoos, A. ;

Wolchok, J. D. .

ANNALS OF ONCOLOGY, 2010, 21 (08) :1712-1717

[3]

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma [J].

Weber, Jeffrey ;

Thompson, John A. ;

Hamid, Omid ;

Minor, David ;

Amin, Asim ;

Ron, Ilan ;

Ridolfi, Ruggero ;

Assi, Hazem ;

Maraveyas, Anthony ;

Berman, David ;

Siegel, Jonathan ;

O'Day, Steven J. .

CLINICAL CANCER RESEARCH, 2009, 15 (17) :5591-5598

[4]

Ipilimumab: controversies in its development, utility and autoimmune adverse events [J].

Weber, Jeffrey .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (05) :823-830

[5]

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study [J].

Wolchok, Jedd D. ;

Neyns, Bart ;

Linette, Gerald ;

Negrier, Sylvie ;

Lutzky, Jose ;

Thomas, Luc ;

Waterfield, William ;

Schadendorf, Dirk ;

Smylie, Michael ;

Guthrie, Troy, Jr. ;

Grob, Jean-Jacques ;

Chesney, Jason ;

Chin, Kevin ;

Chen, Kun ;

Hoos, Axel ;

O'Day, Steven J. ;

Lebbe, Celeste .

LANCET ONCOLOGY, 2010, 11 (02) :155-164